Family Office Of America (FOFA) Shares Outstanding (Weighted Average) (2021 - 2026)
Family Office Of America recorded quarterly Shares Outstanding (Weighted Average) of $30.2 million in Q1 2026, up 13.39% quarter-over-quarter from $26.7 million in Q4 2025, and up 33.87% year-over-year from $22.6 million in Q1 2025.
Family Office Of America's Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $30.2 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 33.87% year-over-year to $30.2 million; the TTM figure through Mar 2026 stood at $30.2 million (up 33.87% YoY), while the FY2025 annual figure was $26.7 million, up 31.65% from the prior year.
- Shares Outstanding (Weighted Average) came in at $30.2 million for Q1 2026 at Family Office Of America, up from $26.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $30.2 million in Q1 2026 to a low of $8.2 million in Q1 2022.
- A 5-year average of $16.4 million and a median of $19.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) grew 1.18% in 2023 and soared 141.15% in 2024, its largest moves.
- Family Office Of America's Shares Outstanding (Weighted Average) stood at $8.3 million in 2022, then gained by 1.71% to $8.5 million in 2023, then jumped by 139.06% to $20.3 million in 2024, then jumped by 31.65% to $26.7 million in 2025, then advanced by 13.39% to $30.2 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $30.2 million, $26.7 million, and $27.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | 30.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.25 Mn |
| Dec 31, 2025 | 26.68 Mn |
| Sep 30, 2025 | 27.33 Mn |
| Jun 30, 2025 | 26.74 Mn |
| Mar 31, 2025 | 22.59 Mn |
| Dec 31, 2024 | 20.26 Mn |
| Sep 30, 2024 | 20.20 Mn |
| Jun 30, 2024 | 20.44 Mn |
| Mar 31, 2024 | 19.73 Mn |
| Dec 31, 2023 | 8.48 Mn |
| Sep 30, 2023 | 8.48 Mn |
| Jun 30, 2023 | 8.48 Mn |
| Mar 31, 2023 | 8.48 Mn |
| Dec 31, 2022 | 8.33 Mn |
| Sep 30, 2022 | 8.29 Mn |
| Jun 30, 2022 | 8.24 Mn |
| Mar 31, 2022 | 8.24 Mn |
| Dec 31, 2021 | 6.93 Mn |
| Sep 30, 2021 | 6.49 Mn |
| Jun 30, 2021 | 5.63 Mn |